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Abstract 1 
Microcephaly with or without chorioretinopathy, lymphoedema, or mental retardation 2 
(MCLMR) (MIM #152950) is a rare autosomal dominant condition for which a 3 
causative gene has recently been identified. Mutations in the kinesin family member 11 4 
(KIF11) gene have now been described in sixteen families worldwide. This is a review 5 
of the condition based on the clinical features of thirty seven individuals from twenty 6 
two families. This report includes nine previously unreported families and additional 7 
information for some of those reported previously.  8 
 9 
The condition arose de novo in 8/20 families (40%). The parental results were not 10 
available for two probands. The mutations were varied, and include missense, nonsense, 11 
frameshift and splice site and are distributed evenly throughout the KIF11 gene. In our 12 
cohort, 86% had microcephaly, 78% had an ocular abnormality consistent with the 13 
diagnosis, 46% had lymphoedema, 73% had mild-moderate learning difficulties, 8% 14 
had epilepsy and 8% had a cardiac anomaly. We identified three individuals with KIF11 15 
mutations, but no clinical features of MCLMR demonstrating reduced penetrance. The 16 
variable expression of the phenotype and presence of mildly affected individuals 17 
indicates that the prevalence may be higher than expected, and we would therefore 18 
recommend a low threshold for genetic testing.  19 
 20 
Keywords 21 
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Introduction 1 
Microcephaly with or without chorioretinopathy, lymphoedema, or mental retardation 2 
(MCLMR) (MIM #152950) is a rare autosomal dominant condition characterised by 3 
variable expression of microcephaly, eye problems including chorioretinopathy, 4 
congenital lymphoedema of the lower limbs, and mild to moderate intellectual 5 
disability. It was originally described by Feingold and Bartoshesky who reported two 6 
unrelated patients in 1992
1
.  7 
 8 
It was recently reported that a significant proportion of cases of MCLMR are caused by 9 
mutations in the kinesin family member 11 (KIF11) gene
2
.  KIF11 encodes EG5, a 10 
homotetramer kinesin motor, likely to be important for the development and 11 
maintenance of retinal and lymphatic structures. Ostergaard et al in 2012, found that 12 
fifteen of twenty families tested had variants in KIF11 that were predicted to be 13 
deleterious, suggesting that a significant proportion of MCLMR cases are caused by 14 
KIF11 mutations, but that the condition is genetically heterogeneous. 15 
 16 
Herein we give a detailed report on the clinical features of thirty seven individuals from 17 
twenty two families (nine previously unreported) with KIF11 mutations and review the 18 
literature, to further delineate this condition.  19 
 20 
Methods 21 
Referral for genetic testing required a diagnosis of MCLMR by a Clinical Geneticist or 22 
chorioretinopathy by an Ophthalmologist. Those with KIF11 mutations were selected; 23 
phenotypic data was collected by review of medical records, patient contact, and clinical 24 
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photographs. The data was summarised by each collaborating clinician and forwarded to 1 
the author for review. Data on certain phenotypic characteristics including level of 2 
intellectual disability was not uniformly collected or standardised. Therefore, the 3 
clinical judgement of the referring clinician was used.  4 
 5 
Mutation Analysis 6 
Genomic DNA was extracted using standard protocols. Parental samples were analyzed 7 
in all but two of the cases. Direct gene sequencing of all twenty two protein-coding 8 
exons and intron-exon boundaries of the KIF11 gene was performed using methods 9 
previously described
2
. All old and new variants reported here are deposited in the 10 
LOVD KIF11 database http://databases.lovd.nl/shared/genes/KIF11 (using accession 11 
number NM_004523.3). 12 
 13 
Results 14 
Twenty KIF11 variants were identified within the cohort (three unrelated families, XIII, 15 
XIV and XV, shared the same nonsense mutation) (Table 1). These twenty mutations 16 
included four missense, six nonsense, six frameshift and four splice site mutations.  17 
 18 
Parental samples were analyzed in all families except X and XVI (a sibling was 19 
available for testing in the latter). In eight cases the mutation was confirmed to have 20 
arisen de novo (40%). The remaining twelve were inherited (60%), with eight (67%) 21 
maternally and four (33%) paternally.  In three families (IV, XVI, XVII) multiple 22 
siblings were affected. There was no significant gender disproportion in probands or 23 
total individuals (Table 2).  24 
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 1 
The predominant features in our cohort were microcephaly, lymphoedema, 2 
chorioretinopathy and intellectual disability (Table 2). Of twenty two probands, all 3 
twenty two (100%) had microcephaly (defined as <-3SD). The microcephaly was 4 
present at birth, with subsequent slow head growth and worsening head circumference 5 
in infancy. In the sibling/parental group, ten out of fifteen mutation positive individuals 6 
had microcephaly, with the remaining five individuals at the lower end of the normal 7 
range (-1.1, -1.4, -2, -2 and -2.5 SD below the mean). Two of these had other features of 8 
MCLMR and, apart from mild learning difficulties in one case; the remaining three 9 
individuals did not have any features of the condition. Overall 32/37 (86%) of 10 
individuals with KIF11 mutations had microcephaly (Table 3). There did not appear to 11 
be any significant correlation between degree of microcephaly in the probands and their 12 
affected parents.  13 
 14 
Chorioretinopathy was also a significant feature and seen in 22/37 (59%) individuals. 15 
Four individuals had not been formally assessed by an ophthalmologist, but all had 16 
preliminary eye examinations. Other ophthalmological findings in this group included 17 
hypermetropia and hypermetropic astigmatism (nine individuals), myopia and myopic 18 
astigmatism (five individuals), bilateral retinal folds (three individuals), microphthalmia 19 
(three individuals), astigmatism (one individual), congenital unilateral retinal 20 
detachment (one individual), persistent hyperplastic primary vitreous (one individual), 21 
and macular retinal pigment epithelium (one individual), corticonuclear cataract, 22 
pseudocoloboma of the left optic nerve and persistent hyaloid artery (one individual); 23 
some individuals had more than one ocular feature (Table 2). A further individual with 24 
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insulin-dependent diabetes mellitus was documented to have diabetic retinopathy. In 1 
total, 29/37 (78%) had ophthalmological features consistent with a diagnosis of 2 
MCLMR (Table 3). 3 
 4 
Lymphoedema was present in seventeen individuals. In all probands (n=12) this was 5 
congenital, bilateral and only affected the lower limbs, (Table 2). The type of swelling 6 
was highly reminiscent of that seen in Milroy disease
3
 with small, dysplastic nails, deep 7 
interphalangeal creases of the toes and swelling particularly of the dorsum of the feet 8 
and toes.  Congenital lymphoedema was not reported in the sibling/parental group; 9 
however five individuals had adult onset oedema. In general this was intermittent, 10 
particularly towards the end of the day. However, one individual did have residual 11 
unilateral leg swelling following a femoral fracture. Two individuals in the cohort had 12 
lymphoscintigraphy, proband XIIIa and her father XIIIb. Lymphoscintigraphy is the 13 
imaging of the lymphatic system by injecting radioactive isotope into the web spaces 14 
between the toes and quantification of uptake into the inguinal lymph nodes after 2 15 
hours. In the proband who presented with congenital lymphoedema, there was no 16 
isotope uptake after two hours. In her father who had mild clinical signs of 17 
lymphoedema, lymphoscintigraphy showed slow uptake in one leg. Overall 17/37 18 
(46%) of those with KIF11 mutations had lymphoedema (Table 3).  19 
 20 
Learning difficulties within the mild-moderate range of impairment were present in 21 
27/37 (73%) of the cohort, this included 17 probands and 10 individuals from the 22 
sibling/parental group (Table 2).  23 
 24 
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Details of dysmorphic features or clinical photographs were available for 34/37 (92%)  1 
individuals; and the characteristic facial phenotype of upslanting palpebral fissures, 2 
broad nose with rounded tip, long philtrum with thin upper lip, and prominent, large 3 
ears were seen in the majority of individuals (Fig.1). Probands IIa and XIa had an 4 
additional chromosome abnormality (paternally inherited 16p13.11 duplication and 5 
paternally inherited 12p12.1 microdeletion respectively), which may have contributed to 6 
the facial phenotype. The parental group did not have the same dysmorphic features 7 
seen in their children; suggesting that any facial dysmorphism may become less obvious 8 
with age. Unfortunately, we did not have childhood photographs of the parental group 9 
for comparison.  10 
 11 
Cardiac abnormalities were documented in three individuals (3/37, 8%), and included 12 
congenital thickened pulmonary valve, atrial septal defect, and patent foramen ovale. A 13 
further individual from the parental group had an acquired hypertrophic cardiomyopathy 14 
possibly secondary to hypertension. Epilepsy was diagnosed in three individuals (3/37, 15 
8%), two with myoclonic epilepsy and a further individual with absence seizures. A 16 
magnetic resonance imaging (MRI) report was only available in one of these patients 17 
(XIII), and this was normal. Two further probands were reported to have possible 18 
seizure activity, but with normal electroencephalograms (EEG). Within the cohort, eight 19 
additional probands underwent MRI to investigate the microcephaly (pedigrees I, III, 20 
VI, VIII, X, XVIII, XIX, XX). In five cases there was normal brain parenchyma (three 21 
of these had reduced cerebral volumes); one child had delayed myelination; one had 22 
some reduction in secondary gyrus; and the remaining had a large cisterna magna and 23 
possible mild frontal pachygyria.  24 
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 1 
In all individuals in whom height had been documented, this fell within the normal 2 
range. One individual also suffered from cystic fibrosis, a further individual was found 3 
to have a midline cleft tongue. Other features seen include mild, bilateral renal 4 
calcinosis of unknown cause, severe hearing loss thought to be secondary to antenatal 5 
exposure to anti-epileptic medication in one individual (VIIIa) whose mother had 6 
epilepsy and a KIF11 mutation, hearing loss in a further individual thought to be 7 
secondary to infection, and umbilical hernia and hypospadias in two further individuals. 8 
Three individuals had behavioural problems.  9 
  10 
Discussion 11 
MCLMR presents with a variable spectrum of central nervous system, lymphatic and 12 
ocular developmental anomalies. Phenotypic abnormalities are described in thirty seven 13 
individuals with mutations in KIF11. Three of these individuals (8%) were found to 14 
carry disease causing mutations but were clinically unaffected. Of the thirty four 15 
clinically affected individuals with KIF11 mutations, microcephaly, chorioretinopathy 16 
and learning difficulties were the most consistent findings, although the presence of 17 
lymphoedema tended to alert the clinician to the diagnosis at an earlier age.  18 
 19 
Microcephaly is usually defined as head circumference of 3 standard deviations below 20 
the mean when adjusted for age and sex (<-3SD)
4
. Primary microcephaly is present at 21 
birth, and is a static developmental anomaly, whereas secondary microcephaly develops 22 
postnatally and indicates a progressive neurodegenerative condition
5
. Pathogenesis is 23 
heterogeneous and both may have genetic or environmental aetiology
6
. The 24 
microcephaly seen in MCLMR is primary
7
, and although the majority of individuals 25 
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(86%) with KIF11 mutations have microcephaly, the clinical spectrum is extremely 1 
variable, ranging from -9.5 standard deviations below the mean, to some individuals 2 
with head circumference in the normal range (-1.1 SD).  3 
 4 
Microcephaly is strongly associated with intellectual disability
8
. Those with learning 5 
difficulties in our cohort were in the mild to moderate range. Although individuals with 6 
microcephaly, chorioretinal dysplasia and severe learning difficulties have been 7 
reported
9
, we would suggest that this is not typical in those with KIF11 mutations. It has 8 
been suggested that abnormal findings of brain anatomy including cerebral atrophy, 9 
cortical dysplasia, myelination delay and white matter hypoplasia are more significantly 10 
correlated with poor developmental performance than the severity of microcephaly
10
. 11 
Brain abnormalities including pachymicrogyria
11
 and lissencephaly
12,13
 have been 12 
reported in association with MCLMR. It is thought that the developmental anomalies in 13 
the retina could be analogous to central nervous system anomalies. One individual 14 
(XX), was reported to have mild pachygyria of the frontal lobes. Interestingly this 15 
individual had a similar ocular phenotype to the case previously reported
11
, although our 16 
patient only had mild learning difficulties.  17 
 18 
There is also an autosomal recessive form of microcephaly and chorioretinopathy with 19 
intellectual disability which is caused by homozygous or biallelic mutations in the 20 
TUBGCP6 gene
14
. The features are similar to MCLMR; however this condition does 21 
not appear to be associated with lymphoedema [Dr Puffenberger, pers. comm.], the 22 
intellectual disability is more severe and polymicrogyria is seen on the brain MRI.  23 
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Epilepsy is a common feature in individuals with microcephaly of all causes
15
. In the 1 
KIF11 cohort, three (8%) of individuals had epilepsy, and a further two individuals had 2 
a history suggestive of possible seizure activity. Therefore epilepsy; in particular 3 
myoclonic epilepsy could be a minor feature of this condition.  4 
 5 
The ocular features of MCLMR have been described as choroidal atrophy and dysplasia 6 
which are thought to be non progressive. The typical fundus features are of focal areas 7 
of lacunar atrophy of the choroid and retina
11
. Other previously reported features 8 
include microphthalmia, myopic and hypermetropic astigmatism and persistent 9 
hyperplastic primary vitreous
9,16,17 
concordant with our observations.  10 
 11 
In 1981, Jarmas et al., reported a family with microcephaly, microphthalmia, bilateral 12 
falciform retinal folds, and blindness
18
, and subsequently, retinal folds were described 13 
in another family with microcephaly, lymphoedema and microphthalmia
19
. Bilateral 14 
retinal folds were seen in two families within our cohort, as was microphthalmia, 15 
suggesting that some cases of Jarmas syndrome could be allelic, but that there is likely 16 
to be genetic heterogeneity of this condition.  17 
 18 
A characteristic facial phenotype with upslanting palpebral fissures, broad nose with 19 
rounded tip, long philtrum with thin upper lip, and prominent ears has been well 20 
documented
7,20
, and this was consistent with the majority of our probands, but became 21 
less prominent with age. Lymphoedema is not seen in all individuals with KIF11 22 
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mutations. It is generally congenital, bilateral and confined to the dorsa of the feet 1 
(Fig.2A), and resembles the lymphoedema seen in Milroy disease
3,21
. It can be seen on 2 
antenatal ultrasound in the third trimester (Fig.2B), and this could be a diagnostic clue 3 
in those with a family history. However, there is likely to be underlying lymphatic 4 
insufficiency in those who do not present with congenital lymphoedema, as a proportion 5 
of individuals had adult onset, intermittent lymphoedema.  6 
 7 
Cardiac defects have been reported in individuals with MCLMR
22
, and were seen in a 8 
small proportion of our cohort. However, cardiac anomalies are a relatively common 9 
congenital abnormality within the general population
23
, therefore it would be difficult to 10 
conclude definitively the association with MCLMR.  Short stature has also been 11 
reported in association with MCLMR
24,25
, however, this was not a feature in any of our 12 
patients and we believe that this is not related to this condition. Recently a midline cleft 13 
tongue was reported
26
 and this individual (I) has been included in our cohort, although 14 
this feature was not present in any other individuals. Midline cleft tongue is a rare 15 
anomaly; it is generally associated with an underlying syndromic diagnosis, most 16 
commonly orofaciodigital syndrome type 1 (OFD1), which is a disorder of the cilia. 17 
OFD1 is characterised by malformations of the face, oral cavity and digits
27
. KIF11 18 
encodes a kinesin which is not a ciliary protein, and therefore we would not expect this 19 
feature to be associated with MCLMR.  It may be that this patient had more than one 20 
diagnosis particularly in view of the parental consanguinity. 21 
 22 
The combination of microcephaly and lymphoedema has been reported in a variety of 23 
conditions including various chromosomal microdeletions (19p13.3, 3q21.1-q21.3, 24 
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5q14.3, 22q13 and 8q24), carbohydrate deficient glycoprotein syndrome type 1a, 1 
progressive encephalopathy-oedema-hypsarrhythmia-optic atrophy (PEHO), Aicardi-2 
Goutieres, and some other rare genetic disorders
28
. However, the phenotype in MCLMR 3 
is quite specific and in general these other conditions have other distinctive features.  4 
 5 
 There appears to be very little genotype-phenotype correlation. Three unrelated 6 
families had the same mutation (c.1159C>T, p.(Arg387*)X) in exon 10 but with 7 
evidence of inter and intra-familial variation. We observed no significant phenotypic 8 
differences between individuals grouped by mutation type, although both cases with 9 
myoclonic epilepsy had missense mutations (c.704C>G, p.(Ser235Cys), and 10 
c.2830C>T, p.(Arg944Cys)), the sample size is too small for accurate interpretation. 11 
There were two families with bilateral retinal folds in the cohort (III, IV). In both 12 
families the mutation was at the terminal end of exon 4 separated only by three 13 
nucleotides (c.385G>T, p.(Glu129*)X and c.387+1G>A, splice mutation), which could 14 
suggest that this feature is particular to mutations in this region. 15 
 16 
There was no significant correlation of clinical features in the three families with the 17 
same mutation to indicate genotype-phenotype association; larger studies would be 18 
required to determine this conclusively.  There was some intra-familial correlation in 19 
the presence/absence of the main clinical features (microcephaly, lymphoedema, 20 
chorioretinal dysplasia, and intellectual disability), in particular pedigrees IV, VIII, 21 
XIV, XV, and XVI. Interestingly, pedigree XXII (c.3016delA, p.(Ile1006Leufs*62)) 22 
appeared to have a milder phenotype, in both the proband and her affected mother. This 23 
frameshift mutation is a single base deletion in the second-to-last exon, and is predicted 24 
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to result in substitution of the terminal 50 residues of the 1,056 amino acid wild type 1 
protein and extension of the reading frame by a further 12 residues
2
. Furthermore, the 2 
parents in pedigrees V and XI, who both carry a pathogenic KIF11 mutation did not 3 
show any clinical features of MCLMR demonstrating reduced penetrance. This suggests 4 
that the prevalence of this condition is likely to be higher than expected. We would 5 
therefore recommend a low threshold for consideration of genetic testing. Genetic 6 
testing should be considered in individuals with isolated microcephaly (particularly if 7 
clearly dominant), congenital lymphoedema but with no mutation in VEGFR3 (the gene 8 
associated with Milroy disease), or chorioretinopathy. Given the incomplete penetrance, 9 
it would also be prudent to perform genetic testing in the parents of apparently sporadic 10 
or isolated cases. 11 
 12 
In conclusion, we have explored the relationship between KIF11 genotype and some of 13 
the major, phenotypic characteristics of MCLMR. We have shown that there is reduced 14 
penetrance and variable expression of the phenotype. Our sample size was relatively 15 
small; therefore analysis of specific genotype-phenotype relationships using a larger set 16 
of MCLMR cases, and to compare the features with those without KIF11 mutations, 17 
would be valuable to further our knowledge of this condition.  18 
 19 
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Figure legends 1 
Fig. 1: A: Clinical photographs showing facial features of the probands with upslanting 2 
palpebral fissures, broad nose with rounded tip, long philtrum with thin upper lip, 3 
prominent chin, and prominent ears. Pedigree no (Left – Right) Row 1 – I, II, III, V, VI, 4 
VIII; Row 2 – IX, XI, XII, XIII, XIV, XV; Row 3 – XVII, XVIII, XIX, XXI, XXII. B: 5 
Parents with less obvious dysmorphism. Pedigree no (Left – Right) Row 1 – II, IX, XII, 6 
XIV, XV, XVII. 7 
 8 
Fig.2. A: Lymphoedema is typically congenital, bilateral and confined to the dorsa of 9 
the feet. B: Lymphoedema of the feet detected by antenatal ultrasound scan. C: Fundal 10 
images demonstrating characteristic changes of chorioretinal dysplasia. 11 
12 
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Table. 1:  Mutation spectrum and inheritance pattern. (Exons are numbered according 1 
to NM_004523.3). 2 
  
Mutation Exon Protein Inheritance 
I
a
 c.139C>T 2 p.(Arg47X*) de novo 
II c.204dup 2 p.(Asp69X*) maternal 
III c.385G>T  4 p.(Glu129X*) de novo 
IV c.387+1G>A 4 to 54i Splice Site  maternal 
V
b c.432T>G 5 p.(Phe144Leu) paternal  
VI
b c.699-2A>G 6 to 76i Splice site de novo 
VII
b c.700C>T 7 p.(Arg234Cys) de novo 
VIII
b c.704C>G 7 p.(Ser235Cys) maternal 
IX c.775G>T  7 p.(Glny259X*) maternal 
X
 c.757_-758del 7 p.(Glu2523Argfs*4) not known 
XI
b c.1039_1040delCT 9 p.(Leu347Glufs*8) paternal  
XII c.1129-4_1133delinsTC 9 to 109i Splice Site maternal 
XIII
b
  c.1159C>T 10 p.(Arg387X*) paternal  
XIV
b c.1159C>T 10 p.(Arg387X*) maternal 
XV c.1159C>T 10 p.(Arg387X*) maternal 
XVI
b
  c.1804C>T 14 p.(Gln602X*) not known 
XVII
b c.1963_1964dupAA 15 p.(His656Serfs*8) paternal  
XVIII c.2267+1G>A 
17 to 
1817i 
Splice Site  de novo 
XIX
b c.2304_2305delCA 18 p.(His768Glnfs*7) de novo 
XX c.2808_2813delinsCA 20 p.(Thr937Argfs*2) de novo 
XXI
b,c
 c.2830C>T 20 p.(Arg944Cys) de novo 
XXII
b c.3016delA 21 p.(Ile1006Leufs*62) maternal 
 
3 
a
Case description in Hazan et al. (2012), 
b
Case description in Ostergaard et al. (2012), 4 
c
Case description in Vasudevan et al. (2005).5 
Formatted: Line spacing:  Double
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Table. 2: Table showing clinical features of all individuals with KIF11 mutations.  
Probands highlighted in blue. Abbreviations are as follows: RPE, retinal pigment epithelium; PHPV, persistent hyperplastic persistent 
vitreous; rt, right; lt, left; PFO, patent foramen ovale; HCM, hypertrophic cardiomyopathy; ASD, atrial septal defect; EEG, 
electroencephalogram; MRI, magnetic resonance imaging; ADHD, attention deficit hyperactivity disorder; -, none; ?, indicates unknown as 
not examined by the authors. 
a
Head circumference measured as occipitofrontal head circumference in cm corrected for age and sex, using 
http://www.phsim.man.ac.uk/SDSCalculator/  to calculate standard deviation. 
b
Height measured in cm and corrected for age and sex. 
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Family 
ID 
Gender OFC
a
 Ophthalmological Findings Lymphoedema 
Learning 
Difficulties 
Characteristic 
Dysmorphic 
Features 
Height
b
 Cardiac Epilepsy Other 
I M -6.3 
Myopia, bilateral 
chorioretinopathy 
Congenital, bilateral, 
pedal 
- Yes 50th PFO - Midline Cleft tongue 
II a M -5.8 Macular RPE. Pale optic discs - Moderate Yes 2nd  - - 
16p13.11 duplication, café 
au lait macules 
II b F -4.1 
Microphthalmia (Not examined 
ophthalmologist) 
Adult onset, lt foot 
intermittent 
Mild Yes, mild ? - - 
Hearing loss secondary to 
infection  
III F -6.4 
Bilateral chorioretinopathy, 
retinal folds, PHPV 
- - Yes ? - - 
MRI - Global reduction of 
brain volume, some 
reduction of secondary 
gyrus 
IV a F -8.6 
Myopic astigmatism, 
vitreoretinal dysplasia. 
Extensive bilateral retinal folds 
- Mild - ? - - - 
IV b M -6.1 Bilateral subretinal folds - - - 9-25th - - - 
IV c F -5.7 - - - - ? - - - 
V a M -5.6 - 
Congenital, bilateral, 
pedal 
- Yes ? - - Cystic Fibrosis 
V b M -1.4 - - - - ? - - - 
VI M -5.5 
Hypermetropic astigmatism, 
bilateral chorioretinopathy 
Congenital, bilateral, 
pedal 
Mild Yes 25th - 
1 vacant 
episode. 
Normal 
EEG & 
MRI 
- 
VII M -5.1 
Hypermetropic astigmatism, 
bilateral chorioretinopathy 
- Moderate ? ? - - - 
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VIII a F -9.5 Bilateral chorioretinopathy - Moderate Yes 2nd  - - 
Mild bilateral renal 
calcinosis (cause 
unknown), severe hearing 
loss (maternal 
antiepileptic medication) 
VIII b F -4.8 Bilateral chorioretinopathy - Mild Yes 50th - 
Juvenile 
myoclonic 
epilepsy 
- 
IX a M -3.8 Bilateral chorioretinopathy 
Congenital, bilateral, 
pedal 
Moderate Yes 9th - - Behavioural problems 
IX b F -2.5 Astigmatism 
Adult onset, feet 
intermittent 
Mild - 9th - - - 
X M -6.9 
Hypermetropic astigmatism, 
nystagmus, bilateral 
chorioretinopathy 
Congenital, bilateral, 
pedal 
Mild-
Moderate 
- ? - - - 
XI a F -7.7 
Hypermetropic astigmatism, 
bilateral chorioretinopathy 
Congenital, bilateral, 
pedal plus pleural 
effusions 
Mild Yes 9th 
Thickened 
Pulmonary 
Valve 
- 
Karyotype - 46, XX, 
del(12)(p12.1p12.2)pat 
XI b M -2 - - Mild Yes, mild 25-50th - - 
Karyotype - 46, XX, 
del(12)(p12.1p12.2) 
XII a M -3.8 
Choroidal changes (Not 
examined by Ophthalmologist) 
Congenital, bilateral, 
pedal 
Moderate Yes 9-25th - - 
Hypertension - cause 
unknown, ADHD, Autism 
XII b F -4.7 
Myopia (Not examined by 
Ophthalmologist) 
Adult onset, 
intermittent 
Mild - ? - - - 
XIII a F -8.7 Bilateral chorioretinopathy  
Congenital, bilateral, 
pedal 
Mild Yes 
0.4th-
2nd 
- 
Absence 
seizures 
- 
XIII b M -2 Hypermetropia, microphthalmia 
Mild, 
lymphoscintigraphy - 
sluggish lt leg 
Mild - 
0.4th-
2nd 
HCM 
(Hypertensi
ve) 
- - 
XIV a M -5.3 
Hypermetropic astigmatism, 
bilateral chorioretinopathy 
- Moderate Yes 9th - - - 
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XIV b F -5.1 
Hypermetropia, bilateral 
chorioretinopathy 
Adult onset, post-
traumatic 
Mild - 0.4th  - - - 
XV a F -6.2 Myopia - Mild Yes 2nd  - - 
Efflorescences at the 
forearm and lower leg, 3 
café au lait spots 
XV b F -5.1 
Myopic astigmatism, bilateral 
chorioretinopathy 
- Mild Yes 9-25th - - Hypothyroidism 
XVI a F -3.9 
Hypermetropic astigmatism, 
bilateral chorioretinopathy   
- - ? ? - - - 
XVI b M -6.1 
Hypermetropia, bilateral 
chorioretinopathy  
- Mild ? ? - - - 
XVII a M -6.4 Bilateral chorioretinopathy 
Congenital, bilateral, 
pedal 
Moderate Yes ? - - - 
XVII b M -5.4 - - - Yes ? - - - 
XVII c M -3.5 Awaiting review - - - ? - - - 
XVIII F -6.4 Bilateral chorioretinopathy  
Congenital, bilateral, 
pedal - Mild 
Mild Yes 9th - 
Possible 
seizure. 
Normal 
EEG 
MRI - Delayed 
myelination. Behavioural 
problems, small umbilical 
hernia 
XIX M -4.8 
Rt retinal detachment, Lt 
peripheral chorioretinopathy 
- Mild Yes 9-25th - - - 
XX M -5.9 
Microphthalmia, bilateral 
chorioretinopathy and 
corticonuclear cataract, pseudo-
coloboma lt optic nerve, 
persistent hyaloid artery 
- Mild Yes 50th - - 
MRI - Large cisterna 
magna, mild pachygyria of 
frontal lobes. Café au lait 
macules, mild syndactyly 
2-3 of toes 
XXI M -5.3 Bilateral chorioretinopathy 
Congenital, bilateral, 
pedal 
Mild Yes 50th ASD 
Myoclonic 
epilepsy 
- 
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XXII a F -4.4 - 
Congenital, bilateral, 
pedal 
- Yes, Mild 9th - - - 
XXII b F -1.1 Diabetic retinopathy - Mild - ? - - - 
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Table 3: Percentage of patients in our cohort with each clinical feature. 
*Some individuals had overlapping ocular features.  
Clinical Feature Percentage of Affected Individuals 
Microcephaly (<3SD) 86% 
Consistent Ocular Abnormality 78% 
* Chorioretinopathy 59% 
* Hypermetropia / Hypermetropic astigmatism 24% 
* Myopia / Myopic astigmatism 14% 
* Retinal folds 8% 
* Microphthalmia 8% 
*Astigmatism 3% 
* Retinal detachment 3% 
*PHPV 3% 
* Macular RPE 3% 
* Corticonuclear cataract, psuedocoloboma left optic nerve, persistent 
hyaloid artery 
3% 
Lymphoedema 46% 
Learning Difficulties 73% 
Epilepsy 8% 
Cardiac Anomaly 8% 
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